Andrea Ruberti MD , Laura Sanchis MD, PhD , Andrea Arenas-Loriente MD , Blanca Domenech-Ximenos MD, PhD , Eduardo Flores-Umanzor MD, PhD , Ander Regueiro MD, PhD , Marta Farrero MD, PhD , Marta Sitges MD, PhD , Xavier Freixa MD, PhD , Omar Abdul-Jawad Altisent MD, PhD
{"title":"Percutaneous Orthotopic Transcatheter Tricuspid Valve Replacement for Native Valve Destruction After Endocarditis","authors":"Andrea Ruberti MD , Laura Sanchis MD, PhD , Andrea Arenas-Loriente MD , Blanca Domenech-Ximenos MD, PhD , Eduardo Flores-Umanzor MD, PhD , Ander Regueiro MD, PhD , Marta Farrero MD, PhD , Marta Sitges MD, PhD , Xavier Freixa MD, PhD , Omar Abdul-Jawad Altisent MD, PhD","doi":"10.1016/j.jaccas.2025.105280","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Transcatheter tricuspid valve replacement (TTVR) is emerging as an option for treating severe tricuspid regurgitation (TR) in patients at high surgical risk.</div></div><div><h3>Case Summary</h3><div>A 59-year-old man with torrential TR and right heart failure following <em>Staphylococcus aureus</em> tricuspid valve infective endocarditis and extensive leaflet destruction was successfully treated with orthotopic TTVR using the LuX-Valve Plus system (Jenscare), resulting in significant clinical improvement and favorable right ventricular remodeling.</div></div><div><h3>Discussion</h3><div>The LuX-Valve Plus, delivered via transjugular access, enables optimal coaxial alignment during deployment. Its unique features—leaflet graspers, a septal anchoring mechanism, and a flexible frame—provide stability and preserve right ventricular function, making it suitable for complex tricuspid anatomies.</div></div><div><h3>Take-Home Messages</h3><div>Orthotopic TTVR with the LuX-Valve Plus offers a viable option for patients with severe TR and extensive leaflet destruction, previously considered ineligible for surgical or transcatheter repair. Multimodality imaging is essential for procedural planning and optimal outcomes.</div></div>","PeriodicalId":14792,"journal":{"name":"JACC. Case reports","volume":"30 30","pages":"Article 105280"},"PeriodicalIF":0.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666084925020613","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Transcatheter tricuspid valve replacement (TTVR) is emerging as an option for treating severe tricuspid regurgitation (TR) in patients at high surgical risk.
Case Summary
A 59-year-old man with torrential TR and right heart failure following Staphylococcus aureus tricuspid valve infective endocarditis and extensive leaflet destruction was successfully treated with orthotopic TTVR using the LuX-Valve Plus system (Jenscare), resulting in significant clinical improvement and favorable right ventricular remodeling.
Discussion
The LuX-Valve Plus, delivered via transjugular access, enables optimal coaxial alignment during deployment. Its unique features—leaflet graspers, a septal anchoring mechanism, and a flexible frame—provide stability and preserve right ventricular function, making it suitable for complex tricuspid anatomies.
Take-Home Messages
Orthotopic TTVR with the LuX-Valve Plus offers a viable option for patients with severe TR and extensive leaflet destruction, previously considered ineligible for surgical or transcatheter repair. Multimodality imaging is essential for procedural planning and optimal outcomes.